- Home
- FCEL vs NKTX Comparison
FCEL vs NKTX Comparison
Compare FCEL & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- NKTX
- Stock Information
- Founded
- FCEL 1969
- NKTX 2015
- Country
- FCEL United States
- NKTX United States
- Employees
- FCEL N/A
- NKTX N/A
- Industry
- FCEL Industrial Machinery/Components
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FCEL Energy
- NKTX Health Care
- Exchange
- FCEL Nasdaq
- NKTX Nasdaq
- Market Cap
- FCEL 144.6M
- NKTX 170.8M
- IPO Year
- FCEL 1992
- NKTX 2020
- Fundamental
- Price
- FCEL $4.70
- NKTX $2.00
- Analyst Decision
- FCEL Hold
- NKTX Strong Buy
- Analyst Count
- FCEL 6
- NKTX 6
- Target Price
- FCEL $14.28
- NKTX $15.00
- AVG Volume (30 Days)
- FCEL 773.4K
- NKTX 2.4M
- Earning Date
- FCEL 03-11-2025
- NKTX 03-26-2025
- Dividend Yield
- FCEL N/A
- NKTX N/A
- EPS Growth
- FCEL N/A
- NKTX N/A
- EPS
- FCEL N/A
- NKTX N/A
- Revenue
- FCEL $114,438,000.00
- NKTX N/A
- Revenue This Year
- FCEL $62.61
- NKTX N/A
- Revenue Next Year
- FCEL $4.68
- NKTX N/A
- P/E Ratio
- FCEL N/A
- NKTX N/A
- Revenue Growth
- FCEL 11.09
- NKTX N/A
- 52 Week Low
- FCEL $4.66
- NKTX $1.31
- 52 Week High
- FCEL $37.20
- NKTX $11.84
- Technical
- Relative Strength Index (RSI)
- FCEL 29.31
- NKTX 59.36
- Support Level
- FCEL $4.66
- NKTX $1.31
- Resistance Level
- FCEL $7.18
- NKTX $2.34
- Average True Range (ATR)
- FCEL 0.40
- NKTX 0.15
- MACD
- FCEL -0.05
- NKTX 0.05
- Stochastic Oscillator
- FCEL 1.78
- NKTX 66.99
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.